As ERα signature, the identified 88 gene set is highly expressed in ERα-positive human breast tumors (Fig. 4b) and the high expression level of the ERα signature is associated with poor overall survival in ERα-positive, lymph node-negative breast cancer patients (Fig. 4c). This evidence concerns the gene ESR1 and breast neoplasm.